Prime Medicine, Inc.

PRMENasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$4.6M

▲ 55.3% YoY

Net Income

-$201.1M

▼ 2.7% YoY

EPS

$-1.35

▲ 18.2% YoY

Cash

$63.0M

▼ 65.5% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.